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Nicotine competes with a visual stimulus for control of 
conditioned responding
Jennifer E. Murray1,2, Nicole R. Wells2, and Rick A. Bevins2
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Abstract
Environmental stimuli that co-occur with tobacco use come to evoke drug-related conditioned 
responses (CRs) that appear involved in continued use of nicotine-containing products. In rats, 
nicotine can serve as a conditional stimulus (CS) for non-drug unconditioned stimuli (USs), 
prompting the question of whether the nicotine CS can compete with, or overshadow, a non-drug 
environmental stimulus for control of a CR. In Experiment 1, male Sprague-Dawley rats were 
assigned to a group [0, 0.01, 0.03, 0.045, or 0.06 mg nicotine (base)/kg/infusion]. During each 
session, there were 10 intravenous infusions followed by a 30-second houselight to form a 
compound CS. At light offset there was 4-second access to sucrose. For Experiment 2, groups 
were nicotine (0.03 mg/kg/infusion) + light compound paired, nicotine + light compound 
unpaired, nicotine paired and light unpaired, and nicotine unpaired and light paired. Paired stimuli 
were presented with sucrose similar to Experiment 1. Unpaired stimuli were temporally separated 
from sucrose. Following acquisition, tests of nicotine and light alone were conducted by 
intermixing non-reinforced trails into training sessions. Nicotine dose-dependently overshadowed 
the light CS as shown by reduced light control of conditioned responding with higher doses. The 
nicotine, light, and nicotine + light compound had to be paired with sucrose to evoke a CR. These 
results demonstrate nicotine overshadows an exteroceptive visual stimulus. Because exteroceptive 
stimuli are often the focus of cue-exposure therapy, such competition may help begin to explain 
the marginal effectiveness of these therapies.
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INTRODUCTION
Possible treatment approaches for tobacco abuse currently range from nicotine replacement 
and other pharmacotherapeutics to a wide variety of behavioral interventions (Fiore et al. 
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2008). Among the behavioral interventions are individual, group and telephone counseling 
that may focus on topics such as problem solving, skills training or contingency 
management (Fiore et al. 2008). One behavioral method uses repeated cue exposure to 
extinguish (reduce) cue-induced reported craving and/or urges. In that therapy, nicotine is 
viewed as an unconditioned stimulus (US). That is, urges for tobacco are often elicited by 
other stimuli (e.g. smell of smoke, pack of cigarettes, etc.) that have come to be associated 
with the nervous system effects of nicotine (Pavlov 1927; Poulos, Hinson & Siegel 1981; 
Conklin & Tiffany 2001; Shiffman et al. 2002; Bevins & Palmatier 2004; Conklin 2006). 
According to conditioning theory, repeated exposure to these conditional stimuli (CSs) 
without the nicotine US should decrease the drug-related conditioned responses (CRs), thus 
decreasing the likelihood of relapse (see Pavlov 1927; Marlatt 1990). Behavioral tobacco 
cessation therapies utilize cue exposure to help reduce the occurrence of drug-related CRs in 
the presence of tobacco-related stimuli (see Conklin & Tiffany 2002; Conklin 2006). 
However, these therapies are only marginally effective (Niaura et al. 1999; Monti & 
MacKillop 2007), suggesting that other factors also contribute to tobacco abuse.
Along with its widespread US effects, nicotine has other stimulus effects that likely 
contribute to the tenacity of tobacco addiction (cf. Bevins 2009). Of particular interest in the 
present report is the recent research in rats showing that nicotine serves as a CS for other 
appetitive USs (e.g. Besheer et al. 2004; Murray & Bevins 2007a,b, 2009; see Discussion). 
That is, when nicotine is differentially paired with intermittent sucrose availability, the 
nicotine state comes to control anticipatory approach to the sucrose receptacle (i.e. goal-
tracking CR; Farwell & Ayres 1979). Although there has only been a single study explicitly 
investigating the CS effects of nicotine in humans (Clements et al. 1996), this learning, and 
related associative processes, likely contributes to development of nicotine dependence as 
well as to high relapse rates (Alessi et al. 2002; Bevins & Palmatier 2004).
During tobacco use nicotine is experienced as a part of a multimodal compound stimulus 
composed of exteroceptive environmental stimuli, as well as the interoceptive stimulus 
effects of the drug. These stimuli may compete with each other for control of conditioned 
responding. The purpose of the present study is to begin to examine overshadowing of an 
exteroceptive stimulus by nicotine. Overshadowing is a form of cue competition in which 
two distinct stimuli are presented together as a compound stimulus controlling behavior 
(Pavlov 1927; Miles & Jenkins 1973). Following compound training, the stimulus elements 
of the compound are evaluated separately for control of responding (e.g. Järbe & Johansson 
1984; Duncan 1986). The control each element has of responding presumably reflects the 
salience (perceptibility) of that element relative to the other element of the compound 
stimulus (Pavlov 1927; Mackintosh 1976). Further, compared with when a stimulus is 
trained alone, a reduction in responding evoked by that stimulus because of its compounding 
with the other has also been viewed as overshadowing (e.g. Matzel, Schachtman & Miller 
1985; Mariathasan & Stolerman 1993; White & Stolerman 1996; Stout et al. 2003).
Because cue-exposure therapies target associations formed between exteroceptive stimuli 
and the effects of tobacco consumption (e.g. Brandon et al. 1995; Waters et al. 2004; 
Conklin 2006), it is of interest to determine whether the CS effects of nicotine can compete 
with an exteroceptive stimulus for control of an appetitive CR. Such competition could result 
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in the exteroceptive stimuli controlling less of the CR than if there was no competition. 
Nicotine as part of the tobacco stimulus may therefore adversely impact the efficacy of 
therapy because the stimulus extinguished as part of the therapy is controlling a weaker CR 
than previously assumed.
There is some research on cue competition and overshadowing involving an interoceptive 
drug stimulus. For instance, early interoceptive effects of morphine administration can serve 
as a CS for later morphine-evoked effects (e.g. Sokolowska, Siegel & Kim 2002) and can 
overshadow an exteroceptive environmental CS (Kim, Siegel & Patenall 1999). In that 
experiment, rats were given IV morphine either gradually over 25–30 minutes or quickly 
over 14–17 seconds before a high dose of morphine was administered in a specific context. 
Both groups showed tolerance to the analgesic effects of the morphine with repeated 
exposure. However, rats that received the slow drug onset as a CS for a higher drug dose 
retained more of the tolerance CR than rats that received a fast drug onset as a CS when the 
external environment was switched at testing. These results were taken as evidence that the 
smaller drug effect presumably experienced with a long drug administration, when given 
before a larger drug onset, can overshadow an exteroceptive context for control of the CR.
To our knowledge the only two published reports on overshadowing with nicotine involve a 
two-lever operant drug discrimination task in which nicotine is an element of a compound 
stimulus composed of two drugs (Mariathasan & Stolerman 1993; White & Stolerman 
1996). In those studies, rats were trained with a mixture of nicotine and midazolam as a 
discriminative stimulus. They found that control of nicotine-appropriate responding was 
overshadowed compared with rats trained with nicotine alone. However, there are no 
published reports examining nicotine overshadowing of an exteroceptive stimulus. Given the 
importance of associative learning processes involving exteroceptive cues in nicotine 
dependence and tobacco use (see Brandon et al. 1995; Conklin & Tiffany 2002; Bevins & 
Palmatier 2004), the current set of experiments examined competition between the nicotine 
CS and a visual CS for control of behavior.
GENERAL METHODS
Subjects
Eighty-three male Sprague-Dawley rats (345 ± 16 g at surgery) from Harlan (Indianapolis, 
IN, USA) were housed individually in clear 48.3 × 26.7 × 20.3 cm (l × w × h) polycarbonate 
cages lined with wood shavings. Water was continuously available in the home cage; access 
to chow (Harlan Teklad Rodent Diet) was restricted as described later. The colony was 
temperature and humidity controlled. Sessions were conducted during the light portion of a 
12 hour light: dark cycle. Protocols were approved by the University of Nebraska-Lincoln 
Animal Care and Use Committee and followed the ‘Guide for the Care and Use of 
Laboratory Animals’ (National Research Council 1996).
Apparatus
Twenty conditioning chambers (ENV-008CT; Medical Associates, Inc., Georgia, VT, USA) 
measuring 30.5 × 24.1 × 21.0 cm (l × w × h) were used. Each chamber was enclosed in a 
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light and sound attenuating cubicle with a fan providing airflow and masking noise. A 
houselight with two bulbs (28 V, 100 mA) was mounted on the back wall of the cubicle. It 
was centered side-to-side, 5 cm below the ceiling and 23.5 cm above the top of the 
conditioning chamber. Chamber sidewalls were aluminum; the ceiling, front, and back walls 
were clear polycarbonate. Chambers were equipped with a recessed receptacle (5.2 × 5.2 × 
3.8 cm; l × w × d) into which a dipper raised 0.1-ml of 26% sucrose solution (w/v). An 
infrared emitter/detector unit, 1.2 cm into the receptacle and 3 cm from the floor, monitored 
head entries. Each chamber contained a spring leash attached to a balanced metal arm with a 
swivel. Tygon® tubing (AAQ04103; VWR, West Chester, PA) extended through the leash 
from a 5-ml syringe mounted on a syringe pump (Medical-Associates, PMH-100VS) located 
outside each cubical. The other end of the tubing was secured to the catheter (see Surgical 
Procedures). A personal computer with Medical Associates interface and software (Medical-
PC for Windows, version IV) controlled infusions and sucrose deliveries and recorded 
dipper entries.
Drugs
(−)-Nicotine hydrogen tartrate from Sigma (St. Louis, MO, USA) was dissolved in 0.9% 
sterile saline and adjusted to a pH of 7.0 ± 0.2 using a dilute NaOH solution. Doses are 
reported in the base form. Infusions were given over 1 second at a volume of 35.7 μl.
Preliminary training
Rats were handled for at least 3 minutes per day for 3 days. Food was removed after 
handling on the last day. Dipper training began the following day in order to establish a high 
baseline of responding. Fifty-min sessions were conducted on 3 consecutive days with each 
session starting on a rat’s first dipper entry. The probability of receiving sucrose decreased 
from 0.167 to 0.05 per 60 seconds over the three sessions (approximately 2.5–0.75 sucrose 
deliveries per minute). After completing the first two sessions, rats received 20 g of food; 
following the third session, free access to food was returned.
Surgical procedures
Surgical implantation of catheters occurred within 2 days of the last preliminary training 
session. Rats were anesthetized with xylazine hydrochloride (20 mg/ml, 1 ml/kg, IP) and 
ketamine hydrochloride (100 mg/ml, 0.6 ml/kg, IP) purchased from Midwest Veterinary 
Supply (Des Moines, IA, USA). One end of a silastic catheter (CamCaths© IVSA28, Ely, 
Cambridgeshire, UK) was implanted into the external left jugular vein. The other end was 
positioned under the skin so that it exited just below the scapulae. The catheter was able to 
be accessed by a metal cannula to which the Tygon tubing was secured. Buprenorphine 
hydrochloride (0.1 mg/kg, SC) was given immediately following surgery. For the evening 
and full day following surgery, buprenorphine (0.5 mg/kg) was available in the drinking 
water to manage post-surgical pain. The catheter was flushed twice a day for the duration of 
the experiment with 0.2 ml of sterile saline mixed with heparin (30 Units/ml; Midwest 
Veterinary Supply) except for the first 5 post-surgical flushes in which 0.1 ml of sterile 
heparinized saline was mixed with streptokinase (c. 8000 Units/ml; Sigma). Rats were 
allowed 5–6 days of recovery in their home cage with free access to food before the start of 
the experiments. Catheter patency was assessed at predetermined points within the 
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experiment with a 0.05 ml xylazine infusion. This concentration produces clear locomotor 
ataxia within 5 seconds (cf. Bevins 2005; Reichel et al. 2009). Only rats with patent 
catheters were included in analyses.
PROCEDURES
Experiment 1: Dose-dependence of nicotine overshadowing a light CS
Training—Rats were assigned to a solution (0, 0.01, 0.03, 0.045, or 0.06 mg/kg nicotine) 
irrespective of preliminary training performance (n = 9 for 0 mg/kg; n = 10 for all others). 
During 2-hour sessions, they received 10 infusions of their assigned solution. Each 1-second 
infusion was followed by the houselight, which remained on for 30 seconds. The offset of 
the houselight coincided with 4-second access to sucrose. Therefore, the 30-second nicotine/
light presentation was conceptualized as the compound CS paired with the sucrose US; the 0 
mg/ kg + light group served as a benchmark for the light CS. The average time to the first 
infusion was 11 minutes with a range of 8–14 minutes; the average time between infusions 
was also 11 minutes with a range of 8–14 minutes. Training continued for 10 sessions.
Testing—Following training, rats were tested to determine the relative control of 
conditioned responding by the nicotine and light elements of the compound CS. Each test 
was conducted across two sessions. In the test session, three test trials (i.e. no sucrose 
following presentation of the stimulus of interest) were intermixed among seven training 
trials. The order of testing each element (i.e. nicotine and light) was counterbalanced such 
that approximately half of the rats in a given group were tested with the light in the first 
session and with nicotine in the second session. Test order was reversed for the remaining 
rats. The first set of test sessions were followed by four more training sessions and a second 
set of test sessions.
Experiment 2: Assessing non-associative explanations for nicotine overshadowing
Training—This experiment was conducted to provide additional control groups for a single 
effective drug dose. Rats were assigned to a group (N−/L+, N+/L−, NL+, or NL−) 
irrespective of preliminary training performance (n = 8 for N−/L+ and NL−; n = 9 for N+/L− 
and NL+). For the group names, N denotes nicotine and L denotes light. The lowest dose of 
nicotine that evoked equivalent responding between nicotine and the light in Experiment 1 
(0.03 mg/kg) was used in all groups. The/indicates a temporal separation of element 
presentations during training. The + indicates which stimulus or stimuli were paired with 
sucrose, and the − indicates the stimulus or stimuli were unpaired with sucrose. Groups with 
paired stimuli (i.e. N−/L+, N+/L−, NL+) were trained as described in Experiment 1. For 
groups whose training included unpaired stimulus presentations (i.e. N−/L+, N+/L−, NL−), 
there were at least 4 minutes between any two stimuli, including any CS and US. Groups 
that had a paired and unpaired stimulus (i.e. N−/L+, N+/L−) received 10 paired and 10 
unpaired presentations. Each CS-US presentation was a mean of 11 minutes apart as in 
Experiment 1. The unpaired stimulus was presented at least 4 minutes from any paired CS-
US presentation. Training continued for 10 sessions.
Testing—Testing and continued training was conducted as described in Experiment 1.
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Dependent measures
Conditioned responding as measured by infrared beam breaks within the sucrose receptacle 
(i.e. dipper entries) during each CS presentation was converted to an elevation score by 
subtracting the number of dipper entries occurring in the 30 seconds before the CS from the 
number of dipper entries that occur during the 30-second CS period. A positive elevation 
score indicates more dipper entries during the CS relative to the same interval immediately 
before CS onset. The elevation score is a widely used measure of conditioned responding in 
Pavlovian conditioning literature that accounts for individual difference in baseline 
responding (e.g. Brooks & Bouton 1994; Simon & Setlow 2006; Murray et al. 2007) and has 
been used recently in a study examining IV nicotine as CS (Murray & Bevins 2009). In 
order to compare responding to the elements across the groups of Experiment 1, we 
converted the data from the element tests into a response ratio. That is, responding to each 
element was divided by the sum of responding on both elements. In Experiment 2, we 
analyzed elevation scores rather than response ratio. Hypothetically, there should be no 
responding for the elements in the NL− group, so normalization would create the appearance 
of effects where none existed.
Data analyses
Conditioned responding during acquisition, testing, and maintenance between tests was 
analyzed using two-way mixed analyses of variance with Dose or Group as the between-
subjects factor and Session or Element as the within-subjects factor for each training and 
testing segment. Significant interactions were followed by pairwise comparisons using 
Fisher’s protected least significant difference (LSD) tests. Statistical significance was 
declared using P < 0.05 for all tests.
RESULTS
Experiment 1: Dose-dependence of nicotine overshadowing a light CS
Training—Figure 1 shows that rats in each group readily acquired the CR at a similar rate 
and to a similar level using the mean elevation scores of each session. The main effect of 
Session, F(9396) = 43.63, P < 0.001, MSE = 5.16, indicated that rats had higher elevation 
scores on all sessions compared with the first session and that there was no significant 
variation after session three, LSDminimum mean difference (mmd) = 0.899. There was no effect of 
Dose or Dose–Session interaction, Fs < 1. After the initial 10-session training, there was a 
set of test sessions (see later) followed by four more training sessions. During those four 
training sessions, rats retained a stable CR. There was no main effect of Dose or Session, Fs 
≤ 1.54, Ps ≥ .201, or Dose–Session interaction, F < 1.
Testing—Figure 2 shows the response ratio for each element during testing (elevation 
scores are shown in Fig. 1). In the first element tests (Fig. 2a), there was a main effect of 
Element, F(1,44) = 38.07, P < 0.001, MSE = 4.74, with a greater proportion of responding 
on the light tests than on the nicotine tests. The ratio of responding on the light and nicotine 
trials varied as a function of nicotine training dose. This impression was supported by a 
significant Group–Element interaction, F(4,44) = 8.90, P < 0.001, MSE = 1.12. The 0 and 
0.01 mg/kg nicotine groups had a greater proportion of responding on the light element than 
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on the nicotine element, LSDmmd = 0.321. In the 0.03, 0.045, and 0.06 mg/kg groups, light 
and nicotine elements controlled an equivalent CR. Further, these groups had a greater 
proportion of nicotine-evoked responding and a lower proportion of light-evoked responding 
than that in the 0 mg/kg group. This data pattern indicates the CS effects of 0.03, 0.045, and 
0.06 mg/kg nicotine overshadowed the light stimulus.
The same pattern of responding was found in the second element tests (Fig. 2b). There was a 
significant main effect of Element, F(1,43) = 41.21, P < 0.001, MSE = 5.15, and a 
significant Group–Element interaction, F(4,43) = 9.15, P < 0.001, MSE = 1.14. The pattern 
of responding was the same as test 1, LSDmmd = 0.326.
Experiment 2: Assessing non-associative explanations for nicotine overshadowing
Training—Conditioned responding appeared to develop to the paired stimulus at a similar 
rate and to a similar level regardless of training group (see Fig. 3). There were only minimal 
changes in responding to unpaired stimuli. For responding to paired stimuli in the first ten 
training sessions, there was no effect of Group or Group–Session interaction, Fs < 1. There 
was a main effect of Session, F(9207) = 26.37, P < 0.001, MSE = 4.13. Examining the 
marginal means of training sessions showed significant increases in responding until session 
four, LSDmmd = 1.116. For responding to unpaired stimuli, there was no main effect of 
Group, F(2,22) = 2.21, P = 0.134, or Group–Session interaction, F(18,198) = 1.49, P = 
0.096. There was a main effect of Session, F(9198) = 2.42, P = 0.012, MSE = 0.397. 
Responding slightly increased across sessions, LSDmmd = 0.352. During the four training 
sessions following the first set of test sessions, responding remained stable to the paired 
stimuli, showing no main effects of Group or Session, Fs < 1, or Group–Session interaction, 
F(6,69) = 1.88, P = 0.097. For responding to the unpaired stimuli, there was no main effect 
of Group or Group–Session interaction, Fs < 1. However, there was a gradual decrease in 
dipper entries across the four sessions resulting in a main effect of Session, F(3,66) = 3.77, P 
= 0.015, MSE = 0.279, LSDmmd = 0.298.
Testing—Figure 4 shows the mean dipper entry elevation scores for element testing in each 
group (also incorporated in Fig. 3). In the first element tests (Fig. 4a), there was no effect of 
Element, F < 1, but there was a main effect of Group, F(3,30), P = 0.002, MSE = 6.38, with 
the NL−group having lower response levels than all other groups, LSDmmd = 2.376. The 
significant Group–Element interaction, F(3,30) = 12.29, P < 0.001, MSE = 7.11, reflects 
differences between the nicotine and light elements in the N−/L+ and N+/L−groups, 
LSDmmd = 2.64. Additionally, light-evoked responding was higher in the N−/L+ group than 
in all other groups; nicotine-evoked responding was higher in the N+/L− group than in the N
−/L+ and NL−groups. Unpaired stimuli were all statistically equivalent to zero.
The findings were similar in the second element tests (Fig. 4b). There was no effect of 
Element, F < 1. The main effect of Group, F(3,30) = 8.43, P < 0.001, MSE = 5.57, indicated 
the NL− group had lower responding than the N−/L+ and NL+ groups, LSDmmd = 2.337. 
The Group–Element interaction, F(3,30) = 16.93, P < 0.001, MSE = 5.541, again suggested 
the only differences between light and nicotine elements occurred in the N−/L+ and N+/L− 
groups, LSDmmd = 2.337. Responding to the light element was higher in the N−/L+ group 
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than all other groups; the N+/L− and NL+ groups responded higher on the nicotine element 
than the N−/L+ and NL− groups.
DISCUSSION
Previous research examining cue competition with nicotine has been limited. As described 
in the Introduction, there have been two cue-competition studies showing that nicotine can 
be overshadowed by midazolam in a two-lever drug discrimination task (Mariathasan & 
Stolerman 1993; White & Stolerman 1996). The present findings extend our understanding 
of the stimulus effects of nicotine in a couple important ways. For instance, this study shows 
that nicotine can overshadow a visual stimulus. Previously, overshadowing of an 
exteroceptive stimulus by an interoceptive stimulus has been shown with morphine (e.g, 
Krimmer et al. 1982) and with pentobarbital (e.g. Järbe & Johansson 1984). In one study, 
rats were trained with saline or pentobarbital consistently paired with either a lit or dark T-
maze apparatus. The combination of the drug and visual cue indicated which turn would 
allow escape from shock. When each element was evaluated for control of the response, the 
group trained with the lower drug dose relied more heavily on the visual cue to indicate 
appropriate responding than the group trained with the higher drug dose (Järbe & Johansson 
1984). Further, overshadowing of the light by nicotine may be particularly relevant given the 
importance of associative processes and nicotine-related stimuli in maintaining tobacco use 
(see Poulos et al. 1981; Niaura et al. 1988; Payne et al. 1991; Brandon et al. 1995; 
Drummond et al. 1995; Conklin & Tiffany 2001; Shiffman et al. 2002; Bevins & Palmatier 
2004; Conklin 2006) and will be discussed below.
For theoretical and empirical reasons we have chosen to discuss nicotine using the 
terminology of the Pavlovian conditioning field (cf. Bevins & Palmatier 2004; Bevins 2009). 
Thus, we conceptualize nicotine in this discriminated goal-tracking task as a CS. In this way, 
we focus on the stimulus-reinforcer relations which have not received nearly the same 
attention in the study of drug states and addiction as the response-reinforcer relation. This is 
not meant to imply that such response-reinforcer relations are not or could not be important 
in this task. A head entry into the dipper must occur to retrieve the sucrose even though the 
actual programmed occurrence of the sucrose is done irrespective of ongoing behavior in 
this task [see Boakes (1977), Farwell & Ayres (1979) and Jenkins (1977) for a more detailed 
discussion of these issues]. Regardless of perspective, we have found evidence of 
neurochemical distinctions between the nicotine stimulus administered subcutaneously in 
the discriminated goal-tracking task when compared with previous publications of the 
nicotine stimulus in a two-lever, drug-discrimination task suggesting that further research 
regarding this distinction across tasks is warranted (Murray & Bevins 2007a; Murray et al. 
2009).
In Experiment 1, overshadowing of the light by nicotine was evidenced by the higher 
training doses significantly reducing the proportion of light-evoked conditioned responding 
compared with the saline group. Notably, we have shown that 0.01 mg/kg nicotine can 
acquire control of a CR within 10 training sessions when not part of a nicotine-light 
compound CS (Bevins 2009), indicating this low dose can function as a CS. In the current 
experiment therefore, the 0.01 mg/kg nicotine was likely overshadowed by light.
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The purpose of Experiment 2 was to provide a nicotine-alone control not evaluated in 
Experiment 1 and to control for total drug exposure across all groups. We only used the 
lowest effective dose to minimize the non-specific effects of the drug while maintaining a 
functional equivalence with the light under the current experimental conditions (0.03 mg/kg/
infusion). That experiment found that stimuli had to be paired with the sucrose US in order 
to exhibit control of responding during element testing. This outcome confirms that 
contiguity with sucrose is necessary for the nicotine to evoke a CR (cf. Murray & Bevins 
2009) and extends the necessity to the light CS. Further, by presenting nicotine unpaired in 
the N−/L+ group, Experiment 2 confirmed that the reduction in light-evoked conditioned 
responding seen in the 0.03 mg/kg group of Experiment 1 was in fact because of nicotine’s 
co-presentation with the light rather than an unconditioned (or non-associative) effect of the 
nicotine. We should note that in the current design, tests for rats in the N+/L− or N−/L+ 
group were identical to reinforced presentations during training; however, for rats in the NL
+ group, test presentations of the elements were different from the compound experienced 
during training. This distinction may have resulted in a generalization decrement during 
testing rather than an overshadowing effect. More research will be required to parse apart 
these two explanations.
Interestingly, even though we did not explicitly look for it, we found limited evidence of 
overshadowing of the nicotine by light. That is, the nicotine-evoked responding in the N+/L
− was the same as in the NL+ group. This result is unlikely because of a ceiling effect of 
responding because at test, the light-evoked response levels in the N−/L+ group appeared 
higher than nicotine-evoked responses in the N+/L− group. Acquisition was statistically 
similar for the paired stimuli between the N+/L− and N−/L+ groups; however, visual 
comparison of the graphs suggests the CR evoked by 0.03 mg/kg nicotine stimulus was 
drifting downward as the CR evoked by light was drifting upward. This pattern may explain 
the finding that nicotine overshadowed the light, but light did not overshadow the 0.03 
mg/kg nicotine in our task. Because of the nature of the stimuli (i.e. nicotine is interoceptive, 
and the light is exteroceptive), the rat may learn to check that the light is on while its head is 
in the dipper, resulting in increased numbers of dipper entries during that CS presentation. 
Conversely, as nicotine is interoceptive, the rat has no need to check that the stimulus is ‘on’, 
and it may begin to reduce its number of dipper entries during the 30 seconds before 
sucrose, resulting in a post-asymptotic response decrement (see Farwell & Ayres 1979 for a 
similar distinction between noise and light CSs).
Another possible explanation for the results also involves the nature of the nicotine stimulus. 
In our experiments, nicotine presentations are an average of 11 minutes apart, meaning that 
there is likely a build-up of background brain levels of nicotine as the session progresses. 
The nicotine ‘stimulus’ in these experiments is the initial peak above baseline evoked by 
each infusion that subsequently fades back somewhat before the next infusion. Notably, the 
human tobacco user likely experiences similar patterns of nicotine exposure. There is a rapid 
increase in brain nicotine levels following a puff from a cigarette that drops relatively 
quickly after the bout of smoking (see Matta et al. 2007). Smokers spend the day titrating 
their blood nicotine levels to a fairly stable background. Perhaps then, having that 
background influences the impact of the discrete light stimulus on nicotine-evoked 
responding. Regardless of the explanation, under the current conditions in these experiments 
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nicotine evoked the same CR regardless of the presence of the exteroceptive light stimulus, 
whereas control by the light was reduced by the presence of nicotine in the stimulus. If these 
results eventuate to generalize to tobacco use in humans, this pattern may have important 
therapeutic implications.
Because nicotine is considered to be the primary addictive component in tobacco (see 
Stolerman & Jarvis 1995; National Institute on Drug Abuse Research Report Series 2006), 
and because associative learning processes are inextricably entwined with tobacco 
consumption, craving, and relapse (see Conklin & Tiffany 2002; Bevins & Palmatier 2004), 
the ability of the interoceptive nicotine CS to overshadow conditioning to the exteroceptive 
stimulus may be particularly relevant to smoking cessation. Treatment approaches involving 
some form of cue-exposure therapy exploit the association between the US effects of 
nicotine and the predictive exteroceptive CS. Both discrete stimuli and contextual 
environmental stimuli have been shown to influence nicotine self-administration in rodents 
(e.g. Caggiula et al. 2001; Wing & Shoaib 2008) as well as tobacco use in human smokers 
(e.g. Conklin 2006; Juliano et al. 2006; Thewissen et al. 2006). Presentation of the drug-
associated cue without the nicotine evokes a response to the cue (e.g. craving, drug seeking; 
Mucha et al. 2008). Repeated exposure without the nicotine can somewhat extinguish CS-
evoked CRs (e.g. Marlatt 1990). This exposure is more effective at reducing craving CRs 
when the stimuli are personalized for the smoker rather than generic smoking imagery 
(Conklin & Tiffany 2001). Further, evaluating cue-evoked reactivity in the smoker’s natural 
environment has also recently been advanced and may prove useful in further personalizing 
the cue exposure therapy (Warthen & Tiffany 2009).
The long-term effectiveness of these sorts of therapies, however, has been limited (see 
Niaura et al. 1999; Monti & MacKillop 2007). If the stimulus properties of nicotine are 
capable of forming compound stimuli with the cues that are targeted during cessation 
therapy, then those target cues may be controlling a weaker CR than they would have been 
had there been no competition by nicotine. Further, similar to a generalization account of our 
current results, presentation of the exteroceptive cues alone may produce a response 
decrement from when the cues are experienced concurrently with nicotine, resulting in a 
similar effect. Finally, based on the results of the current study, the stimulus effects of 
nicotine may not be as impacted by the presence of an exteroceptive light stimulus as the 
exteroceptive light stimulus is by the presence of nicotine. Albeit speculative, perhaps in 
vivo exposure to nicotine could be presented as part of the target stimulus in exposure 
therapies to help extinguish cravings.
Urges to engage in drug use have been shown to be increased by a small dose of the target 
substance (see Niaura et al. 1988), and there is some precedent for drug inclusion in cue-
exposure therapy. For example, presentations of priming doses of alcohol in alcoholics 
evoked craving CRs that gradually diminished with repeated presentations (Laberg & 
Ellertsen 1987). Similarly, the ability to resist drinking a second dose of alcohol increased 
with repeated trials, suggesting attenuation of the CR with experience (Rankin, Hodgson & 
Stockwell 1983). Controlled exposure to the stimulus effects of nicotine could be used in 
conjunction with cue-exposure therapy. Nicotine is already available in the form of over-the-
counter nicotine replacement therapy (NRT). Indeed, there has been some success with NRT 
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as a smoking cessation aid (e.g. Müller et al. 1990; Schneider et al. 1995). In a recent meta-
analysis, approximately 17% of subjects on NRT remained abstinent for 6 months compared 
with about 10% of subjects on placebo or no treatment (Woolacott et al. 2002). At 12 
months, 16% of NRT subjects remained abstinent compared with 10% of placebo/no-
treatment subjects. The success rate varied depending on the route of administration and was 
related to pharmaco-kinetic similarity to cigarettes. The nasal spray delivery form of NRT 
was the most effective at both time points with quit rates of approximately 24%, whereas the 
least effective form was the patch with a 14 and 13% quit rate at 6 and 12 months, 
respectively. Further, when nicotine patches were given as treatment along with cue 
exposure in the form of smoking denicotinized cigarettes, that combination of therapy 
resulted in higher abstinence rates after 4 weeks than when placebo patches were used with 
the denicotinized cigarettes (Becker, Rose & Albino 2008). Whether this success was 
because of the NRT replacing ‘rewarding’ effects of nicotine for which NRT was designed, 
because of the extinction of nicotine-evoked CRs as speculated in this discussion, or some 
combination of the two, remains to be determined. Because there is some evidence that 
nicotine replacement does not completely eliminate cue-evoked craving (Waters et al. 2004), 
much more research is clearly needed at both the level of basic learning and at the level of 
clinical treatment to better understand the relation between nicotine and the predictive CSs. 
Based on the findings of these experiments, more consideration should be given to the 
nicotine CS and how this stimulus may affect the formation and expression of other 
smoking-related associations.
Acknowledgments
We thank Jessica D. Barr, Carmela M. Reichel, Amanda M. Struthers, and Jamie L. Wilkinson for their assistance 
with surgeries. JEM was supported by F31 DA025399. NRW was partially supported by UNL Undergraduate 
Creative Activities and Research Experiences (UCARE). The research was supported by DA018114 awarded to 
RAB and an American Psychological Association Dissertation Research Award and a Psi Chi Graduate Student 
Research Grant awarded to JEM. None of these sources had a role in the study design; the collection, analysis, and 
interpretation of data; in the writing of the paper; or the decision to submit the paper for publication. MED-PC 
programs used in the present article are available in a slightly modified version upon request to Rick A. Bevins, 
Department of Psychology, University of Nebraska-Lincoln, Lincoln NE USA 68588-0308, or rbevins1@unl.edu.
References
Alessi SM, Roll JM, Reilly MP, Johanson C-E. Establishment of a diazepam preference in human 
volunteers following differential-conditioning history of placebo versus diazepam choice. Exp Clin 
Psychopharmacol. 2002; 10:77–83. [PubMed: 12022801] 
Becker KM, Rose JE, Albino AP. A randomized trial of nicotine replacement therapy in combination 
with reduced-nicotine replacement therapy in combination with reduced-nicotine cigarettes for 
smoking cessation. Nicotine Tob Res. 2008; 10:1139–1148. [PubMed: 18629723] 
Besheer J, Palmatier MI, Metschke DM, Bevins RA. Nicotine as a signal for the presence or absence 
of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats. 
Psychopharmacology. 2004; 172:108–117. [PubMed: 14530902] 
Bevins RA. The reference-dose place conditioning procedure yields a graded dose-effect function. Int J 
Comp Psychol. 2005; 18:101–111.
Bevins, RA. Altering the motivational function of nicotine through conditioning processes. In: Bevins, 
RA., Caggiula, AR., editors. The Motivational Impact of Nicotine and Its Role in Tobacco Use: The 
55th Nebraska Symposium on Motivation. New York: Springer; 2009. p. 111-129.
Bevins RA, Palmatier MI. Extending the role of associative learning processes in nicotine addiction. 
Behav Cogn Neurosci Rev. 2004; 3:143–158. [PubMed: 15653812] 
Murray et al. Page 11
Addict Biol. Author manuscript; available in PMC 2017 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Boakes, RA. Performance on learning to associate a stimulus with positive reinforcement. In: Davis, 
H., Hurwitz, HMB., editors. Operant-Pavlovian Interactions. Hillsdale, NJ: Erlbaum; 1977. p. 
67-97.
Brandon, TH., Piasecki, TM., Quinn, EP., Baker, TB. Cue exposure treatment in nicotine dependence. 
In: Drummond, DC.Tiffany, ST.Glautier, S., Remington, B., editors. Addictive Behaviour: Cue 
Exposure Theory and Practice. West Sussex: John Wiley and Sons Ltd; 1995. p. 211-227.
Brooks DC, Bouton ME. A retrieval cue for extinction attenuates response recovery (renewal) caused 
by a return to the conditioning context. J Exp Psychol Anim Behav Process. 1994; 20:366–379.
Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, 
Sved AF. Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem 
Behav. 2001; 70:515–530. [PubMed: 11796151] 
Clements K, Glautier S, Stolerman IP, White J-AW, Taylor C. Classical conditioning in humans: 
nicotine as CS and alcohol as US. Hum Psychopharmacol. 1996; 11:85–95.
Conklin CA. Environments as cues to smoke: implications for human extinction-based research and 
treatment. Exp Clin Psychopharmacol. 2006; 14:12–19. [PubMed: 16503701] 
Conklin CA, Tiffany ST. The impact of imagining personalized versus standardized urge scenarios on 
cigarette craving and autonomic reactivity. Exp Clin Psychopharmacol. 2001; 9:399–408. 
[PubMed: 11764016] 
Conklin CA, Tiffany ST. Applying extinction research and theory to cue-exposure addiction 
treatments. Addiction. 2002; 97:155–167. [PubMed: 11860387] 
Drummond, DC., Tiffany, ST., Glautier, S., Remington, B. Cue exposure in understanding and treating 
addictive behaviours. In: Drummond, DC.Tiffany, ST.Glautier, S., Remington, B., editors. 
Addictive Behaviour: Cue Exposure Theory and Practice. West Sussex: John Wiley and Sons Ltd; 
1995. p. 1-17.
Duncan PM. The effect of training dose on discrimination of compound drug-exteroceptive stimuli. 
Psychopharmacology. 1986; 90:543–547. [PubMed: 3101110] 
Farwell BJ, Ayres JJB. Stimulus-reinforcer and response-reinforcer relations in the control of 
conditioned appetitive headpoking (‘goal-tracking’) in rats. Learn Motiv. 1979; 10:295–312.
Fiore, MC., Jaén, CR., Baker, TB., Bailey, WC., Benowitz, NL., Curry, SJ., Dorfman, SF., Froelicher, 
ES., Goldstein, MG., Healton, CG., Henderson, PN., Heyman, RB., Koh, HK., Kottke, TE., Lando, 
HA., Mecklenburg, RE., Mermelstein, RJ., Mullen, PD., Orleans, CT., Robinson, L., Stitzer, ML., 
Tommasello, AC., Villejo, L., Wewers, ME. Clinical Practice Guideline. Rockville, MD: U.S. 
Department of Health and Human Services Public Health Service; 2008. Treating Tobacco Use 
and Dependence: 2008 Update. 
Järbe TUC, Johansson B. Interaction between drug discriminative stimuli and exteroceptive, sensory 
signals. Behav Neurosci. 1984; 98:686–694. [PubMed: 6466444] 
Jenkins, HM. Sensitivity of different response systems to stimulus-reinforcer and response-reinforcer 
relations. In: Davis, H., Hurwitz, HMB., editors. Operant-Pavlovian Interactions. Hillsdale, NJ: 
Erlbaum; 1977. p. 47-62.
Juliano LM, Donny EC, Houtsmuller EJ, Stitzer ML. Experimental evidence for a causal relationship 
between smoking lapse and relapse. J Abnorm Psychol. 2006; 115:166–173. [PubMed: 16492107] 
Kim JA, Siegel S, Patenall VRA. Drug-onset cues as signals: intraadministration associations and 
tolerance. J Exp Psychol Anim Behav Process. 1999; 25:491–504. [PubMed: 10531660] 
Krimmer, EC., Benson, BJ., McGuire, MS., Barry, H, III. Conditional sensory stimuli during morphine 
discrimination. In: Colpaert, FC., Slangen, JL., editors. Drug Discrimination: Applications in CNS 
Pharmacology. Amsterdam: Elseiver Biomedical Press; 1982. p. 135-145.
Laberg JC, Ellertsen B. Psychophysiological indicators of craving in alcoholics: effects of cue 
exposure. Br J Addict. 1987; 82:1341–1348. [PubMed: 3480748] 
Mackintosh NJ. Overshadowing and stimulus intensity. Anim Learn Behav. 1976; 4:186–192. 
[PubMed: 964444] 
Mariathasan EA, Stolerman IP. Overshadowing of nicotine discrimination in rats: a model for 
behavioural mechanisms of drug interactions? Behav Pharmacol. 1993; 4:209–215. [PubMed: 
11224188] 
Murray et al. Page 12
Addict Biol. Author manuscript; available in PMC 2017 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Marlatt GA. Cue exposure and relapse prevention in the treatment of addictive behaviors. Addict 
Behav. 1990; 15:395–399. [PubMed: 2248112] 
Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, 
Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, 
Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose 
JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM. Guidelines on 
nicotine dose selection for in vivo research. Psychopharmacology. 2007; 190:269–319. [PubMed: 
16896961] 
Matzel LD, Schachtman TR, Miller RR. Recovery of an overshadowed association achieved by 
extinction of the overshadowing stimulus. Learn Motiv. 1985; 16:398–412.
Miles CG, Jenkins HM. Overshadowing in operant conditioning as a function of discriminability. 
Learn Motiv. 1973; 4:11–27.
Monti, PM., MacKillop, J. Advances in the treatment of craving for alcohol and tobacco. In: Miller, 
PM., Kavanagh, D., editors. Translation of Addictions Science into Practice. New York: Elsevier 
Science; 2007. p. 211-237.
Mucha RF, Pauli P, Weber M, Winkler M. Smoking stimuli from the terminal phase of cigarette 
consumption may not be cues for smoking in healthy smokers. Psychopharmacology. 2008; 
201:81–95. [PubMed: 18704373] 
Müller P, Abelin T, Ehrsam R, Imhof P, Howald H, Mauli D. The use of transdermal nicotine in 
smoking cessation. Lung. 1990; 168(Suppl):445–453. [PubMed: 2117147] 
Murray JE, Bevins RA. Behavioral and neuropharmacological characterization of nicotine as a 
conditional stimulus. Eur J Pharmacol. 2007a; 561:91–104. [PubMed: 17343849] 
Murray JE, Bevins RA. The conditional stimulus effects of nicotine vary as a function of training dose. 
Behav Pharmacol. 2007b; 18:707–716. [PubMed: 17989508] 
Murray JE, Bevins RA. Acquired appetitive responding to intravenous nicotine reflects a Pavlovian 
conditioned association. Behav Neurosci. 2009; 123:97–108. [PubMed: 19170434] 
Murray JE, Li C, Palmatier MI, Bevins RA. The interoceptive Pavlovian stimulus effects of caffeine. 
Pharmacol Biochem Behav. 2007; 86:838–846. [PubMed: 17477964] 
Murray JE, Wells NR, Lyford GD, Bevins RA. Investigation of endocannabinoid modulation of 
conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 
in adult male ratas. Psychopharmacology. 2009; 205:655–665. [PubMed: 19495728] 
National Institute on Drug Abuse Research Report Series. Tobacco Addiction. 2006. NIH Publication 
number 06-4342
National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: 
National Academy Press; 1996. 
Niaura R, Abrams DB, Shadel WG, Rohsenow DJ, Monti PM, Sirota AD. Cue exposure treatment for 
smoking relapse prevention: a controlled clinical trial. Addiction. 1999; 94:685–695. [PubMed: 
10563033] 
Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Pedraza M, Abrams DB. Relevance of cue reactivity 
to understanding alcohol and smoking relapse. J Abnorm Psychol. 1988; 97:133–152. [PubMed: 
3290304] 
Pavlov, IP. Conditioned Reflexes. London: Oxford University Press; 1927. 
Payne TJ, Schare ML, Levis DJ, Colletti G. Exposure to smoking-relavent cues: effects on desire to 
smoke and topographical components of smoking behavior. Addict Behav. 1991; 16:467–479. 
[PubMed: 1801570] 
Poulos CX, Hinson RE, Siegel S. The role of Pavlovian processes in drug tolerance and dependence: 
implications for treatment. Addict Behav. 1981; 6:205–211. [PubMed: 7293843] 
Rankin H, Hodgson R, Stockwell T. Cue exposure and response prevention with alcoholics: a 
controlled trial. Behav Res Ther. 1983; 21:435–446. [PubMed: 6626114] 
Reichel CM, Murray JE, Grant KM, Bevins RA. Bupropion attenuates methamphetamine self-
administration in adult male rats. Drug Alcohol Depend. 2009; 100:52–62.
Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME, Steinberg C. Efficacy of a 
nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction. 
1995; 90:1671–1682. [PubMed: 8555958] 
Murray et al. Page 13
Addict Biol. Author manuscript; available in PMC 2017 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Shiffman S, Gwaltney CJ, Balabanis MH, Liu KS, Paty JA, Kassel JD, Hickcox M, Gnys M. 
Immediate antecedents of cigarette smoking: an analysis from ecological momentary assessment. J 
Abnorm Psychol. 2002; 111:531–545. [PubMed: 12428767] 
Simon NW, Setlow B. Post-training amphetamine administration enhances memory consolidation in 
appetitive Pavlovian conditioning: implications for drug addiction. Neurobiol Learn Mem. 2006; 
86:305–310. [PubMed: 16750404] 
Sokolowska M, Siegel S, Kim JA. Intraadministration associations: conditional hyperalgesia elicited 
by morphine onset cues. J Exp Psychol Anim Behav Process. 2002; 28:309–320. [PubMed: 
12136706] 
Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive. Psychopharmacology. 1995; 
117:2–10. [PubMed: 7724697] 
Stout S, Arcediano F, Escobar M, Miller RR. Overshadowing as a function of trial number: dynamics 
of first- and second-order comparator effects. Learn Behav. 2003; 31:85–97. [PubMed: 18450071] 
Thewissen R, Snijders SJBD, Havermans RC, van den Hout M, Jansen A. Renewal of cue-elicited urge 
to smoke: implications for cue exposure treatment. Behav Res Ther. 2006; 44:1441–1449. 
[PubMed: 16375853] 
Warthen MW, Tiffany ST. Evaluation of cue reactivity in the natural environment of smokers using 
ecological momentary assessment. Exp Clin Psychopharmacol. 2009; 17:70–77. [PubMed: 
19331483] 
Waters AJ, Shiffman S, Sayette MA, Patty JA, Gwaltney CJ, Balabanis MH. Cue-provoked craving 
and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol. 2004; 72:1136–
1143. [PubMed: 15612859] 
White JA, Stolerman IP. Reversal of overshadowing in a drug mixture discrimination in rats. 
Psychopharmacology. 1996; 123:46–54. [PubMed: 8741954] 
Wing VC, Shoaib M. Contextual stimuli modulate extinction and reinstatement in rodents self-
administering intravenous nicotine. Psychopharmacology. 2008; 200:357–365. [PubMed: 
18587561] 
Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, Raftery JP, Aveyard PN, Hyde 
CJ, Barton PM. The clinical effectiveness and cost-effectiveness of bupropion and nicotine 
replacement therapy for smoking cessation: a systematic review and economic evaluation. Health 
Technol Assess. 2002; 6:16.
Murray et al. Page 14
Addict Biol. Author manuscript; available in PMC 2017 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Acquisition and maintenance of compound stimulus training. Mean conditioned responding 
[±1 standard error of the mean (SEM)] for each training session in all groups is shown (a). 
Conditioned responding in acquisition and maintenance phases of compound training with 
results of the element test sessions (+1 SEM) are shown for the individual training groups 
(b–f ).The order of element test presentation is for display purposes only; they were 
conducted in a counterbalanced manner (see Procedures). Significant results are described in 
the text
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Figure 2. 
Tests 1 and 2 (a and b, respectively) of the proportion of total elevation scores (+1 SEM) for 
responding on the nicotine and light test trials for each of the five groups are shown. * 
denotes significant difference between proportion of responding on the nicotine and light 
elements within the group. + denotes a significantly higher proportion of nicotine-evoked 
responding compared with the 0 mg/kg group. # denotes a significantly lower proportion of 
light-evoked responding compared with the 0 mg/kg group
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Figure 3. 
Acquisition and maintenance of stimulus training. Mean elevation scores (±1 standard error 
of the mean) of acquisition and element tests for the four training groups in Experiment 4 (a, 
b, c and d display the N−/L+, N+/L−, NL+, and NL− groups, respectively) are shown. The 
order of element test presentation is for display purposes only; they were conducted in a 
counterbalanced manner (see Procedures). Significant effects are described in the text
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Figure 4. 
Tests 1 and 2 (a and b, respectively) of elevation scores (+1 standard error of the mean) for 
the nicotine and light test trials for each of the four groups are shown. * denotes significant 
difference between responding on the nicotine and light elements within the group. + 
denotes significantly lower nicotine-evoked responding compared with the N+/L− group. # 
denotes significantly lower light-evoked responding compared with the N−/L+ group
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